Lupin announces US launch of Formoterol Fumarate Inhalation Solution

Pallavi Madhiraju- November 29, 2022 0

Indian pharma company Lupin Limited has launched Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial in the US market. The product is a ... Read More

FDA refuses to approve AstraZeneca’s sBLA for Fasenra in CRSwNP

pallavi123- March 19, 2022 0

The US Food and Drug Administration (FDA) has refused to approve the supplemental biologics license application (sBLA) of AstraZeneca’s asthma drug Fasenra (benralizumab) for the ... Read More

Lupin Limited gets approval for Luforbec 100/6 µg pMDI in UK

pallavi123- June 20, 2021 0

Lupin Limited said that its subsidiary Lupin Healthcare (UK) has secured approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for Luforbec (beclometasone dipropionate/formoterol ... Read More

Lupin Limited launches Digital Asthma Educator platform in India

Pallavi Madhiraju- June 8, 2021 0

Indian pharma company Lupin Limited has launched its Digital Asthma Educator platform, which is said to guide asthma patients on the right technique of using ... Read More

Glenmark gets FDA nod for Theophylline Extended-Release Tablets generic

pallavi123- June 4, 2021 0

Glenmark Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for Theophylline Extended-Release Tablets, 300 mg, and 450 mg. The Indian ... Read More

China’s CF PharmTech raises $50m in Series F round for inhalation products

pharmanewsdaily- July 2, 2020 0

CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The ... Read More

Pulmazole phase 2 clinical study gets FDA approval for Pulmazole in allergic bronchopulmonary aspergillosis

pharmanewsdaily- February 10, 2019 0

Pulmatrix, the Massachusetts-based biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to initiate a phase 2 clinical trial for Pulmazole ... Read More

Dupixent receives FDA approval for treatment of moderate-to-severe asthma

pharmanewsdaily- October 21, 2018 0

Sanofi and Regeneron Pharmaceuticals' Dupixent (dupilumab) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving it as an add-on maintenance ... Read More

AstraZeneca and Amgen secure FDA breakthrough designation for asthma drug tezepelumab

pharmanewsdaily- September 9, 2018 0

In a significant advancement for asthma treatment, AstraZeneca, in partnership with Amgen, has received the coveted breakthrough therapy designation from the US Food and Drug ... Read More

Amazing Asafoetida benefits in treating Stomach Upsets

pharmanewsdaily- April 23, 2018 1

Asafoetida commonly known as hing is used in the seasoning of foods to add taste and flavor to the dishes in addition to providing many ... Read More

1210 / 13 Posts